Evidence map›Paper›PMID 42609893›Full record

ArticleProceedings. IEEE International Conference on Healthcare Informatics2026

Interpretable Alzheimer's Diagnosis via Multimodal Fusion of Regional Brain Experts.

Farica Zhuang, Shu Yang, Dinara Aliyeva, Zixuan Wen, Duy Duong-Tran, Christos Davatzikos, Tianlong Chen, Song Wang, Li Shen

Abstract read
In one paragraph

Article in Proceedings. IEEE International Conference on Healthcare Informatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Farica ZhuangUniversity of Pennsylvania, Philadelphia, USA.
Shu YangUniversity of Pennsylvania, Philadelphia, USA.
Dinara AliyevaUniversity of North Carolina, Chapel Hill, USA.
Zixuan WenUniversity of Pennsylvania, Philadelphia, USA.
Duy Duong-TranUniversity of Pennsylvania, Philadelphia, USA.
Christos DavatzikosUniversity of Pennsylvania, Philadelphia, USA.
Tianlong ChenUniversity of North Carolina, Chapel Hill, USA.
Song WangUniversity of Central Florida, Orlando, USA.
Li ShenUniversity of Pennsylvania, Philadelphia, USA.

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
Peripheral and Central Biomarkers of Alzheimer's Disease in Diverse CohortsU19AG074879 · NIA · MAYO CLINIC JACKSONVILLE · PI Minerva Maria Carrasquillo · 2023 to 2026
$42.0M
Technology Identification and Training CoreP30AG073105 · NIA · UNIVERSITY OF PENNSYLVANIA · PI DEMIRIS, GEORGE, KARLAWISH, JASON H · 2021 to 2025
$21.2M
Ultrascale Machine Learning to Empower Discovery in Alzheimers Disease BiobanksU01AG068057 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Christos Davatzikos, Heng Huang · 2020 to 2026
$20.7M
Artificial Intelligence Strategies for Alzheimer's Disease ResearchU01AG066833 · NIA · CEDARS-SINAI MEDICAL CENTER · PI MOORE, JASON H., RITCHIE, MARYLYN D · 2022 to 2025
$6.7M
Translational big data analytic approaches to advance drug repurposing for Alzheimer's diseaseR01AG071470 · NIA · UNIVERSITY OF PENNSYLVANIA · PI KIM, DOKYOON, NING, XIA · 2021 to 2025
$3.8M
Robust and Interpretable Multi-modal AI/ML for Precision MedicineR01EB037101 · NIBIB · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Tianlong Chen · 2025 to 2026
$1.4M
Novel integrative imaging genetics analysis for Alzheimer's disease riskand progressionR01AG068191 · NIA · YALE UNIVERSITY · PI ZHAO, YIZE · 2024 to 2025
$1.2M
NIA NIH HHS P30 AG073105NIA NIH HHS R01 AG068191NIA NIH HHS R01 AG071470NIA NIH HHS U01 AG024904NIA NIH HHS U01 AG066833NIA NIH HHS U01 AG068057NIA NIH HHS U19 AG074879NIBIB NIH HHS R01 EB037101
6 · The paper itself

Abstract

Accurate and early diagnosis of Alzheimer's disease (AD) is critical for effective intervention and requires integrating complementary information from multimodal neuroimaging data. However, conventional fusion approaches often rely on simple concatenation of features, which cannot adaptively balance the contributions of biomarkers such as amyloid PET and MRI across brain regions. In this work, we propose MREF-AD, a Multimodal Regional Expert Fusion model for AD diagnosis. It is a Mixture-of-Experts (MoE) framework that models mesoscopic brain regions within each modality as independent experts and employs a gating network to learn subject-specific fusion weights. Utilizing tabular neuroimaging and demographic information from the Alzheimer's Disease Neuroimaging Initiative (ADNI), MREF-AD achieves competitive performance over strong classic and deep baselines while providing interpretable, modality- and region-level insight into how structural and molecular imaging jointly contribute to AD diagnosis. The source code is available at https://github.com/PennShenLab/mref-ad.

Indexed as

Alzheimer’s diseaseamyloid PETmagnetic resonance imaging (MRI)mixture of expertsmultimodal imaging

Identifiers

PMID42609893
PMCPMC13480405

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.